ClinicalTrials.Veeva

Menu
C

Clinical Research Specialists, LLC | Kissimmee, FL

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

BI 1015550
PLN-74809
Olodaterol
Bexotegrast
Buloxibutid
Nerandomilast
BI 1819479
DUPIXENT®
Tiotropium
PF-07275315

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 11 total trials

A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast (FIBRONEER™-ON)

This study is open to people with idiopathic pulmonary fibrosis (IPF) or progressive pulmonary fibrosis (PPF). They can only take part if they have c...

Enrolling
Progressive Pulmonary Fibrosis
Idiopathic Pulmonary Fibrosis
Drug: Nerandomilast

The purpose of this clinical trial is to learn about the effects and safety of the study medicine PF-07275315 for the potential treatment of COPD. CO...

Enrolling
Moderate to Severe Chronic Obstructive Pulmonary Disease
Drug: Placebo
Drug: PF-07275315-dose 2

This study is open to people aged 40 years or older who have at least 1 family member with pulmonary fibrosis. Pulmonary fibrosis is a condition wher...

Enrolling
Interstitial Lung Abnormalities
Interstitial Lung Diseases
Drug: Placebo
Drug: Nerandomilast

The ASPIRE trial is a 52 week randomized, double-blind, placebo-controlled, parallel-group, multicenter trial in which the efficacy, safety, and phar...

Active, not recruiting
Idiopathic Pulmonary Fibrosis (IPF)
Drug: Placebo
Drug: Buloxibutid

Trial sponsors

Boehringer Ingelheim logo
Pfizer logo
P
Regeneron Pharmaceuticals logo
V

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems